» Authors » I BRUDERMAN

I BRUDERMAN

Explore the profile of I BRUDERMAN including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 86
Citations 274
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Abboud S, Witman S, Rosenfeld M, Guber A, Zissin R, BRUDERMAN I
Comput Biol Med . 1998 Oct; 28(3):193-206. PMID: 9784959
The feasibility of estimating the forced expiratory volume-time curve from the amplitude modulation of the electrocardiogram was studied using a numerical torso model and ECG signal processing. A two dimensional...
2.
BRUDERMAN I, Abboud S
Telemed J . 1997 Jul; 3(2):127-33. PMID: 10168278
Objectives: To describe a newly developed telespirometry system consisting of a portable spirometer that transmits the lung ventilatory values by telephone from the patient's home to a remote monitoring center...
3.
Cohen R, Guber A, Siegal A, BRUDERMAN I, Huszar M, Yellin A, et al.
Cancer . 1997 Feb; 79(3):468-73. PMID: 9028356
Background: In a previous study, the authors used a variety of anticytokeratin monoclonal antibodies to show that a large proportion of lung tumors cytologically diagnosed as squamous cell carcinoma contain...
4.
Abboud S, BRUDERMAN I
Thorax . 1996 Apr; 51(4):407-10. PMID: 8733494
Background: A new portable spirometer, the Spirophone, has been developed that records a subject's blow and can then transmit all the data by telephone to a receiving centre for analysis...
5.
Barnea O, Abboud S, Guber A, BRUDERMAN I
Comput Biol Med . 1996 Mar; 26(2):123-31. PMID: 8904286
New lung function indices based on a lumped parameter model of the maximal expiratory flow-volume (MEFV) curve are presented. The waveforms obtained by the model were compared to the flow-volume...
6.
Sredni B, Xu R, Albeck M, Gafter U, Gal R, Shani A, et al.
Int J Cancer . 1996 Jan; 65(1):97-103. PMID: 8543404
The immunomodulator AS101 has been demonstrated to exhibit radioprotective and chemoprotective effects in mice. Following phase-I studies, preliminary results from phase-II clinical trials on non-small-cell-lung-cancer patients showed a reduction in...
7.
Sredni B, Albeck M, Tichler T, Shani A, Shapira J, BRUDERMAN I, et al.
J Clin Oncol . 1995 Sep; 13(9):2342-53. PMID: 7666093
Purpose: The aim of this study was to evaluate the ability of the immunomodulator AS101 to prevent chemotherapy-induced neutropenia and thrombocytopenia and thus allow patients to receive full-dose antineoplastic agents...
8.
Abboud S, Barnea O, Guber A, Narkiss N, BRUDERMAN I
Med Eng Phys . 1995 Jul; 17(5):332-6. PMID: 7670692
A mathematical simulation of the maximum expiratory flow-volume (MEFV) curve was developed using a lumped parameter model. The model uses a theoretical approximation of an activation function representing the lung's...
9.
Guber A, Cohen R, Ronah R, Zan Bar I, Geiger B, BRUDERMAN I
Chest . 1994 Jan; 105(1):138-43. PMID: 7506136
In the current study a comparative analysis of keratin typing and DNA content was carried out in human lung tumors from transthoracic fine needle aspiration biopsies (TFNAB) (18 patients) or...
10.
Schwartz H, Kemp J, Bianco S, Bone M, BRUDERMAN I, Rebuck A, et al.
J Allergy Clin Immunol . 1993 Jul; 92(1 Pt 2):204-9. PMID: 8393032
No abstract available.